Avalo Therapeutics (AVTX) EPS (Diluted) (2015 - 2026)
Avalo Therapeutics (AVTX) EPS (Diluted) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.33 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.15 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.19 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Avalo Therapeutics | 854.16 Mn | 453.89 Mn | - | -0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.83 |
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -1.02 |
| Sep 30, 2025 | -2.19 |
| Jun 30, 2025 | -1.92 |
| Mar 31, 2025 | -1.25 |
| Dec 31, 2024 | -4.71 |
| Sep 30, 2024 | 2.14 |
| Jun 30, 2024 | 12.87 |
| Mar 31, 2024 | -141.14 |
| Dec 31, 2023 | -29.41 |
| Sep 30, 2023 | -26.81 |
| Jun 30, 2023 | -140.62 |
| Mar 31, 2023 | -203.65 |
| Dec 31, 2021 | -1.87 |
| Sep 30, 2021 | 2.18 |
| Jun 30, 2021 | 2.06 |
| Mar 31, 2021 | -3.44 |
| Dec 31, 2020 | 21.53 |
| Sep 30, 2020 | -7.61 |